Protagonist Therapeutics Inc (PTGX)
41.69
+1.04
(+2.56%)
USD |
NASDAQ |
Nov 21, 16:00
41.69
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Market Cap: 2.485B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.423B |
| November 19, 2024 | 2.303B |
| November 18, 2024 | 2.407B |
| November 15, 2024 | 2.450B |
| November 14, 2024 | 2.446B |
| November 13, 2024 | 2.543B |
| November 12, 2024 | 2.573B |
| November 11, 2024 | 2.771B |
| November 08, 2024 | 2.755B |
| November 07, 2024 | 2.837B |
| November 06, 2024 | 2.837B |
| November 05, 2024 | 2.736B |
| November 04, 2024 | 2.787B |
| November 01, 2024 | 2.787B |
| October 31, 2024 | 2.732B |
| October 30, 2024 | 2.834B |
| October 29, 2024 | 2.883B |
| October 28, 2024 | 2.869B |
| October 25, 2024 | 2.813B |
| October 24, 2024 | 2.795B |
| October 23, 2024 | 2.773B |
| October 22, 2024 | 2.764B |
| October 21, 2024 | 2.736B |
| October 18, 2024 | 2.796B |
| October 17, 2024 | 2.799B |
| Date | Value |
|---|---|
| October 16, 2024 | 2.797B |
| October 15, 2024 | 2.836B |
| October 14, 2024 | 2.759B |
| October 11, 2024 | 2.683B |
| October 10, 2024 | 2.595B |
| October 09, 2024 | 2.630B |
| October 08, 2024 | 2.617B |
| October 07, 2024 | 2.607B |
| October 04, 2024 | 2.641B |
| October 03, 2024 | 2.639B |
| October 02, 2024 | 2.677B |
| October 01, 2024 | 2.641B |
| September 30, 2024 | 2.678B |
| September 27, 2024 | 2.625B |
| September 26, 2024 | 2.647B |
| September 25, 2024 | 2.718B |
| September 24, 2024 | 2.744B |
| September 23, 2024 | 2.718B |
| September 20, 2024 | 2.788B |
| September 19, 2024 | 2.705B |
| September 18, 2024 | 2.637B |
| September 17, 2024 | 2.645B |
| September 16, 2024 | 2.721B |
| September 13, 2024 | 2.770B |
| September 12, 2024 | 2.689B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
127.60M
Minimum
Dec 03 2019
2.883B
Maximum
Oct 29 2024
1.144B
Average
1.096B
Median
Aug 14 2023
Market Cap Benchmarks
| Johnson & Johnson | 374.39B |
| Assembly Biosciences Inc | 94.01M |
| Precision BioSciences Inc | 49.94M |
| Entrada Therapeutics Inc | 676.37M |
| NovaBay Pharmaceuticals Inc | 3.508M |
Market Cap Related Metrics
| PE Ratio | 15.67 |
| PS Ratio | 7.954 |
| Price to Book Value | 4.671 |
| Price to Free Cash Flow | 11.23 |
| Price | 41.69 |
| Earnings Yield | 6.38% |
| Operating PE Ratio | 17.27 |
| Normalized PE Ratio | 15.67 |